Open AccessImmunogenicity and safety of a heterologous prime-boost COVID-19 vaccine schedule: ChAdOx1 vaccine Covishield followed by BBV152 Covaxin
Author(s) -
Rajni Kant,
Gaurav Raj Dwivedi,
Kamran Zaman,
Rima R. Sahay,
Gajanan Sapkal,
Himanshu Kaushal,
Dimpal A. Nyayanit,
Pragya D. Yadav,
Gururaj Deshpande,
Rajeev Singh,
Sandeep Chaowdhary,
Nivedita Gupta,
Sanjay Kumar,
Priya Abraham,
Samiran Panda,
Balram Bhargava
Publication year - 2021
Publication title -
journal of travel medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.985
H-Index - 59
eISSN - 1708-8305
pISSN - 1195-1982
DOI - 10.1093/jtm/taab166
Subject(s) - heterologous , immunogenicity , medicine , vaccination , virology , immunology , immunization , adverse effect , regimen , antibody , biology , gene , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom